These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 13130390)

  • 41. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic strategies for behavioral and psychological symptoms (BPSD) in demented patients.
    Torta R; Badino E; Scalabrino A
    Arch Gerontol Geriatr Suppl; 2004; (9):443-54. PubMed ID: 15207446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
    Ihl R; Tribanek M; Bachinskaya N
    J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
    Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
    Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
    J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral and psychological symptoms of dementia: factor analysis and relationship with cognitive impairment.
    Poletti M; Nuti A; Cipriani G; Bonuccelli U
    Eur Neurol; 2013; 69(2):76-82. PubMed ID: 23154430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
    Deberdt WG; Siegal A; Ahl J; Meyers AL; Landbloom R
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):364-9. PubMed ID: 17708584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    Matsuzono K; Yamashita T; Ohta Y; Hishikawa N; Koike M; Sato K; Kono S; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 47(2):487-93. PubMed ID: 26401570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project.
    Boccardi V; Conestabile Della Staffa M; Baroni M; Ercolani S; Croce MF; Ruggiero C; Mecocci P;
    J Alzheimers Dis; 2017; 60(4):1275-1283. PubMed ID: 29036823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural substances in psychiatry (Ginkgo biloba in dementia).
    Itil T; Martorano D
    Psychopharmacol Bull; 1995; 31(1):147-58. PubMed ID: 7675979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial.
    Napryeyenko O; Sonnik G; Tartakovsky I
    J Neurol Sci; 2009 Aug; 283(1-2):224-9. PubMed ID: 19286192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategies for the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
    CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case-control study regarding relative factors for behavioural and psychological symptoms of dementia at a Canadian regional long-term extended care facility: a preliminary report.
    Sawa M; Chan P; Donnelly M; McKenna M; Osaki Y; Kishimoto T; Ganesan S
    Psychogeriatrics; 2014 Mar; 14(1):25-30. PubMed ID: 24397473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
    Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
    Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?
    Dekker AD; Strydom A; Coppus AM; Nizetic D; Vermeiren Y; Naudé PJ; Van Dam D; Potier MC; Fortea J; De Deyn PP
    Cortex; 2015 Dec; 73():36-61. PubMed ID: 26343344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antipsychotic drug use and favourable natures of emotional functions in patients with dementia.
    Fujii M; Butler JP; Sasaki H
    Psychogeriatrics; 2019 Jul; 19(4):320-324. PubMed ID: 30784147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.